Biokey Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Biokey General Information

Description

Provider of formulation and process development services intended to support clients in all stages of development ranging from sketches to ANDA, IND, and NDA filings. The company's services involve deploying their formulation and process teams to apply their extensive scientific knowledge and experience to deliver assistance to the clients in the fields of API characterization, pre-formulation studies, formulation development, analytical method development, stability studies, IND/NDA/ANDA/510K submissions and manufacturing clinical trial materials (phase 1 through phase 3) and commercial manufacturing, enabling clients to avail the required results within specified a time-frame.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Consulting Services (B2B)
Biotechnology
Parent Company
Primary Office
  • 44370 Old Warm Springs Boulevard
  • Fremont, CA 94538
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biokey Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-Feb-2019 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 09-Apr-2010 000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 27-Oct-2006 0000 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 13-Dec-2004 $1.16M $4.66M 000.00 Completed Startup
1. Early Stage VC (Series A) 29-Jan-2001 $3.5M $3.5M 00.00 Completed Startup
To view Biokey’s complete valuation and funding history, request access »

Biokey Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.00 00 00 00 00 00.000
Series C Nonvoting 000,000 00.00 00 00 00 00 0.000
Series B 1,160,000 $0.06 $1 $1 1x $1 3.87%
Series A 7,000,000 $0.03 $0.5 $0.5 1x $0.5 23.33%
To view Biokey’s complete cap table history, request access »

Biokey Executive Team (3)

Name Title Board Seat Contact Info
San-Laung Chow President & Chief Executive Officer
Mark Shih Ph.D Director, Quality Control & Analytical Services
George Lee Ph.D Founder, Chairman & Vice President
To view Biokey’s complete executive team members history, request access »

Biokey Board Members (1)

Name Representing Role Since
George Lee Ph.D Biokey Founder, Chairman & Vice President 000 0000
To view Biokey’s complete board members history, request access »

Biokey Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amkey Ventures Venture Capital Minority 000 0000 000000 0
Kenson Ventures Venture Capital Minority 000 0000 000000 0
To view Biokey’s complete investors history, request access »